At BioTech X-ray, we’re proud to stand at the forefront of healthcare innovation—not just in diagnostics, but in policy. In March, our leadership team traveled to Washington, D.C. to support the reintroduction of the Providing Urgent Relief through Medicare Access to Diagnostic Imaging (PURE) Act – H.R. 2477.